A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemiaPaul J. Hampel, Philip A. Thompson, Mahesh Swaminathan et al.|Blood Advances|2024Cited by 19
Time-limited pirtobrutinib, venetoclax, and obinutuzumab combination in first-line chronic lymphocytic leukemiaNitin Jain, William G. Wierda, Vanthana Bharathi et al.|Blood|2025Cited by 3